Get the Weekly Intelligence Brief — top committee picks every Sunday.
BKD · NYSE · STOCK

Brookdale Senior Living Inc.

Healthcare Updated August 11, 2026
$12.56
52W $7.03 – $17.09
51/100
$3.00B
-21.7
0.61
AI Committee Verdict
Watch
51/100
Conviction: Contested · 50% agreement · 4 analysts
Contested

Is BKD Bullish or Bearish?

Mixed. Innellis AI committee rates Brookdale Senior Living Inc. (BKD) Watch with a composite score of 51/100 , based on 4 analysts with 50% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +9.27 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -10.73 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 18.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • RSI at 16 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Price trading below the lower Bollinger Band -- stretched to the downside — Technical
  • Bollinger bandwidth of 18.0% signals elevated volatility — Risk
  • News sentiment is negative (-0.17 across 6 articles, 14d) — News
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
51/100
Agreement
50%
Analysts
4
Conviction
Contested
Sector Rank
Top 95%
of 192 Healthcare peers
Technical Analyst bearish
38 / 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 16 is in oversold territory (could mean either capitulation or a bounce setup)
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 18.0% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst neutral
52 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.17 across 6 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
15.7
Oversold
MACD Histogram
-0.227
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$11.71
Resistance
$14.55
Bollinger %B
-0.27
Below Lower Band
Price vs Moving Averages
EMA 9
$13.99 Below
EMA 21
$14.37 Below
EMA 50
$14.33 Below
EMA 200
$12.80 Below

Fundamental Analysis

Valuation
100
Profitability
25
Financial Health
64
Cash Flow
70
Valuation
P/E Ratio -21.7×
P/B Ratio
PEG Ratio -0.53
Dividend Yield 0.00%
52W High $17.09
52W Low $7.03
Quality & Growth
ROE
ROA -441.3%
Gross Margin 1443.2%
Operating Margin 375.1%
Revenue Growth YoY
Debt / Equity -44.49
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -21.7 (inexpensive relative to a 15-40x range); Price-to-book of -103.6x; PEG ratio of -0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 587.0%; Return on assets of -4.4%; Net margin of -4.6%; Gross margin of 14.4%; Current ratio of 1.14 (tight short-term liquidity); Debt-to-equity of -44.49; Free cash flow per share is positive (0.36); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full BKD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore BKD Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime